• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 10220
Device Problems Coagulation in Device or Device Ingredient (1096); Use of Device Problem (1670); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/16/2016
Event Type  malfunction  
Manufacturer Narrative
Device lot #, manufacture date, and expiry are not available at this time.Investigation: during customer follow-up, the physician stated that 800mg of calcium chloride (cacl2) per 100ml of saline is infused at 75ml/h and after reviewing the patient's chart, it was determined that the patient's calcium usage may have contributed to the clotting that they observed during the procedure.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that near the end of red blood cell depletion/exchange (rbcdx)procedure, they have seen clotting in the tubing set.The customer stated that the clotting was observed 'in the circuits' late into the procedure.During this procedure, they had increased the hematocrit 5% points from the starting procedure.They did not adjust the anti-coagulant ratio when clots were observed, instead, they flushed the access line.Patient information and outcome are not available at this time.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information.Investigation: during customer follow-up, the customer stated that she was only aware of one patient in particular that clotting occurred during a procedure.She reviewed the patient's chart and noted that the patient underwent the procedures on (b)(6) 2016.However, she was unsure of the procedural dates when the clotting issues occurred.Investigation is in process.A follow-up report will be provided.
 
Manufacturer Narrative
Investigation: the run data file (rdf) was analyzed for this event.Interface images determined that there were no indications of clumping in the channel.The customer did not provide the lot number pertaining to this event,therefore a device history record (dhr) search could not be conducted for this specific incident.All lots must meet acceptance criteria before release.Root cause:the root cause for this particular issue is unknown at this time.Possible causes include but are not limited to:- patient physiology- patient access problem- ac ratio issues- need for the addition of saline during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w collins ave
lakewood, CO 80215
3032392246
MDR Report Key6149418
MDR Text Key62127257
Report Number1722028-2016-00633
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K153601
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 12/06/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number10220
Other Device ID Number05020583102200
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/16/2016
Initial Date FDA Received12/06/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received01/19/2017
03/07/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-